Inorganic Chemistry
Article
sec
[(TsN4)CuI(MeCN)]PF6 (4). Yellow crystalline solid. Isolated yield: 29
mg (20%, low yield because the product was sparingly soluble in
MeCN). Complex 4 remains fluxional in a CD3CN solution even when
cooled to −30 °C. The effective symmetry of the ligand is C2v, which
could be due to the presence of only the κ4 isomer or due to a fast,
unresolved exchange process. 1H NMR (600 MHz, −30 °C, CD3CN):
δ 7.89 (d, 3JHH = 7.8 Hz, −(SO2)CCHCH−Ar, 4H), 7.66−7.42 (br m, p-
(
BuN4)CuII (7). Bright-yellow crystalline solid. Isolated yield: 64 mg
(42%). Complex 7 exists as a single isomer (κ3-secBuN4)CuII in a CD2Cl2
solution at −30 °C. κ3-7. 1H NMR (600 MHz, −30 °C, CD2Cl2): δ 7.26
(t, 3JHH = 7.6 Hz, p-HPy, 2H), 6.91 (d, 3JHH = 7.6 Hz, m-HPy, 1H), 6.85
3
(d, JHH = 7.9 Hz, m-HPy, 1H), 6.7−6.6 (m, two overlapping m-HPy,
2H), 5.02 (dd, 2JHH = 2.4 and 13.0 Hz, −PyCH2N−, 1H), 4.76 (d, 2JHH
= 13.0 Hz, −PyCH2N−, 1H), 4.32−4.24 (m, two overlapping CH2N,
2H), 3.96−3.87 (m, two overlapping CH2N, 2H), 3.60 (vd, 2JHH = 15.0
Hz, two overlapping CH2N, 2H), 3.28−3.23 (m, −NCH(CH3)-
(CH2CH3), 1H), 2.91−2.85 (m, −NCH(CH3)(CH2CH3)−, 1H),
2.54−2.48 (m, −CHCH2CH3, 1H), 1.74−1.67 (m, −CHCH2CH3,
H
Py and −CHCCH3−Ar, 6H), 7.08−6.83 (br m, m-HPy, 4H), 5.29 (br s,
−PyCH2N−, 4H), 3.59 (br s, −PyCH2N−, 4H), 2.50 (s, CH3−Ar, 6H),
1.96 (s, CH3CN, 3H). 13C NMR (151 MHz, −30 °C, CD3CN): δ 153.9
(quat, CPy), 146.2 (−CHCCH3−Ar), 140.2 (−(SO2)CCH−Ar), 138.9
(p-CPy), 131.1 (CHCCH3−Ar), 129.1 (−(SO2)CCHCH−Ar), 124.6
(m-CPy), 56.8 (−PyCH2N−), 21.5 (CH3−Ar). Anal. Found (calcd for
C30H31CuF6N5O4PS2): C, 44.67 (45.14); H, 3.88 (3.91); N, 8.60
(8.77).
3
1H), 1.47−1.35 (m, −CHCH2CH3, 2H), 1.42 (d, JHH = 6.7 Hz,
−CHCH3, 3H), 1.20 (d, 3JHH = 6.5 Hz, −CHCH3−, 3H), 1.01 (t, 3JHH
= 7.4 Hz, −CH2CH3, 3H), 1.00 (t, 3JHH = 7.3 Hz, −CH2CH3, 3H); four
partially overlapping signals of m-H of Py and eight signals for PyCH2−
arms are observed because of the asymmetric environment caused by
the presence of sec-butyl and κ3 coordination of the ligand. 13C NMR
(151 MHz, −30 °C, CD2Cl2): δ 159.97, 159.92, 159.88 (quat, CPy; two
signals are not resolved due to overlap), 154.79, 154.70, 154.65, 154.56
(quat, CPy), 136.69 (p-CPy), 124.60, 124.53, 124.46, 124.39 (m-CPy),
121.57, 121.49, 121.41, 121.33 (m-CPy), 66.39, 65.52 (−NCHCH3),
62.94, 62.82, 60.89 (br), 59.53 (br), 58.25, 58.12 (−PyCH2N), 27.63,
27.62 (−CH2CH3), 15.83, 15.61 (−CHCH3), 11.87 (−CH2CH3);
because of the asymmetric environment caused by sec-butyl groups and
the presence of two diastereomers, four sets of signals were observed for
meta and para protons of Py and several overlapping sets of signals for
aliphatic protons. Anal. Found (calcd for C22H32N4CuI): C, 48.30
General Procedure for the Synthesis of (RN4)CuII (5−10). To a
stirred solution of RN4 (1.0 equiv) in dry tetrahydrofuran (THF) was
added CuI (0.95 equiv) to immediately produce a bright-yellow
suspension. Within 10 min, the suspended solids dissolved, and after 2−
5 h, a bright-yellow solid appeared. THF was removed by vacuum
R
i
evaporation, and dichloromethane (for N4 complexes; R = Me, Bu,
secBu, neoPent, Pr) or a dichloromethane/methanol solution (for the
i
TsN4 complex) was added to dissolve all of the reaction mixture. The
solution was passed through a Celite plug and allowed to crystallize by
diethyl ether vapor diffusion over 1−2 days. Crystalline solids were
collected, washed with ether and hexane, and dried under vacuum.
Crystals suitable for X-ray analysis were obtained by the slow diffusion
of diethyl ether vapors into dichloromethane (5−9) or a dichloro-
methane/methanol solution (10).
(48.67); H, 5.80 (5.94); N, 10.02 (10.32).
i
BuN4)CuII (8). Bright-yellow crystalline solid. Isolated yield: 78 mg
(iPrN4)CuII (5). Bright-yellow crystalline solid. Isolated yield: 120 mg
(
(51%). Complex 6 exists as a single isomer (κ3-iBuN4)CuII in a CD2Cl2
solution at −30 °C. κ3-8. 1H NMR (600 MHz, −30 °C, CD2Cl2): δ 7.30
(t, 3JHH = 7.6 Hz, p-HPy, 2H), 6.84 (d, 3JHH = 7.6 Hz, m-HPy, 2H), 6.73
(d, 3JHH = 7.5 Hz, m-HPy, 2H), 4.94 (d, 2JHH = 13.5 Hz, −PyCH2N−,
2H), 4.35 (d, 2JHH = 15.1 Hz, −PyCH2N−, 2H), 4.05 (d, 2JHH = 13.5
Hz, −PyCH2N−, 2H), 3.85 (d, 2JHH = 15.1 Hz, −PyCH2N−, 2H), 3.30
(76%). At −30 °C, [(κ3-iPrN4)CuII] and [(κ4-iPrN4)CuII] isomers were
present in a CD2Cl2 solution in a 91.2:8.8 ratio by NMR integration. κ3-
5, major isomer. 1H NMR (600 MHz, −30 °C, CD2Cl2): δ 7.27 (t, 3JHH
= 7.7 Hz, p-HPy, 2H), 6.89 (d, 3JHH = 7.8 Hz, m-HPy, 2H), 6.68 (d, 3JHH
=
7.8 Hz, m-HPy, 2H), 4.85 (d, 2JHH = 12.9 Hz, −PyCH2N−, 2H), 4.32 (d,
2
2JHH = 14.8 Hz, −PyCH2N−, 2H), 3.94 (d, JHH = 12.9 Hz,
3
3
(d, JHH = 6.3 Hz, −NCH2CH−, 2H), 2.41 (d, JHH = 7.3 Hz,
−NCH2CH−, 2H), 2.32−2.26 (m, −CH2CH(CH3)2, 1H), 2.01−1.95
(m, −CH2CH(CH3)2, 1H), 1.09 (d, 3J HH = 6.8 Hz, −CH(CH3)2, 6H),
0.99 (d, 3J HH = 6.6 Hz, −CH(CH3)2, 6H). 13C NMR (151 MHz, −30
°C, CD2Cl2): δ 156.9 (quat, CPy), 155.0 (quat, CPy), 136.4 (p-CPy),
124.0 (m-CPy), 121.3 (m-CPy), 71.3 (−NCH2CH−), 63.7
(−NCH2CH− and −PyCH2C), 63.3 (−PyCH2C), 26.9 (−CH2CH-
(CH3)2), 26.1 (−CH2CH(CH3)2), 22.8 (−CH(CH3)2), 20.4 (−CH-
(CH3)2). Anal. Found (calcd for C23H34N4CuI): C, 48.72 (48.67); H,
5.89 (5.94); N, 10.35 (10.32).
2
−PyCH2N−, 2H), 3.66−3.62 (m, −CH(CH3)2−, 1H), 3.56 (d, JHH
= 14.8 Hz, −PyCH2N−, 2H), 3.26−3.21 (m, −CH(CH3)2−, 1H), 1.46
3
3
(d, J
= 6.7 Hz, −CH(CH3)2, 6H), 1.23 (d, J
= 6.7 Hz,
HH
HH
−CH(CH3)2, 6H). 13C NMR (151 MHz, −30 °C, CD2Cl2): δ 159.8
(quat, CPy), 154.6 (quat, CPy), 136.7 (p-CPy), 124.4 (m-CPy), 121.4 (m-
CPy), 60.1 (−PyCH2N−), 59.9 (−PyCH2N−), 59.4 (−CH(CH3)2−),
59.1 (−CH(CH3)2−), 19.4 (−CH(CH3)2), 19.2 (−CH(CH3)2). κ4-5,
minor isomer. 1H NMR (600 MHz, −30 °C, CD2Cl2): δ 7.22 (t, 3JHH
=
7.7 Hz, p-HPy, 2H), 4.14 (d, 2JHH = 14.8 Hz, −PyCH2N−, 4H), 3.74−
2
3.70 (m, −CH(CH3)2−, 2H), 3.42 (d, JHH = 14.8 Hz, −PyCH2N−,
(
MeN4)CuII (9). Bright-yellow crystalline solid. Isolated yield: 101 mg
4H), 1.32 (br d, −CH(CH3)2, 12H). The peaks of the meta protons of
pyridine cannot be detected because of their low intensity. 13C NMR
(151 MHz, −30 °C, CD2Cl2): δ 156.9 (quat, CPy), 135.9 (p-CPy), 121.9
(m-CPy), 56.1 (−CH(CH3)2−). The PyCH2N− and methyl peaks
might be merging with another isomer peak. Anal. Found (calcd for
CH2Cl2·3C20H28CuIN4): C, 44.82 (44.96); H, 5.17 (5.32); N, 10.12
(59%). At −30 °C, [(κ4-MeN4)CuII] and [(κ3-MeN4)CuII] isomers
were present in a CD2Cl2 solution in a 63.5:36.5 ratio by NMR
integration. κ4-9, major isomer. 1H NMR (600 MHz, −30 °C, CD2Cl2):
δ 7.20 (t, 3JHH = 7.9 Hz, p-HPy, 2H), 6.61 (d, 3JHH = 7.4 Hz, m-HPy, 4H),
2
2
4.03 (d, JHH = 14.8 Hz, −PyCH2N−, 4H), 3.40 (d, JHH = 14.8 Hz,
−PyCH2N−, 4H), 2.90 (s, −NCH3, 6H). 13C NMR (151 MHz, −30
°C, CD2Cl2): δ 156.2 (quat, CPy), 136.0 (p-CPy), 121.8 (m-CPy), 64.5
(−PyCH2N−), 50.1 (−NCH3). κ3-7, minor conformer. 1H NMR (600
MHz, −30 °C, CD2Cl2): δ 7.32 (t, 3JHH = 7.7 Hz, p-HPy, 2H), 6.88 (d,
3JHH = 7.4 Hz, m-HPy, 2H), 6.75 (d, 3JHH = 7.4 Hz, m-HPy, 2H), 4.92 (d,
(10.31).
neo
(
PentN4)CuII (6). Bright-orange crystalline solid. Isolated yield: 99
mg (66%). Complex 6 exists as a single isomer (κ3-neoPentN4)CuII in a
CD2Cl2 solution at −30 °C. κ3-6. H NMR (600 MHz, −30 °C,
1
2JHH = 13.6 Hz, −PyCH2N−, 2H), 4.29 (d, JHH = 15.3 Hz,
2
CD2Cl2): δ 7.27 (t, 3JHH = 7.5 Hz, p-HPy, 2H), 7.01 (d, 3JHH = 7.5 Hz, m-
HPy, 2H), 6.66 (d, 3JHH = 7.5 Hz, m-HPy, 2H), 4.94 (d, 2JHH = 12.8 Hz,
−PyCH2N−, 2H), 4.45 (d, 2JHH = 14.9 Hz, −PyCH2N−, 2H), 4.08 (d,
2JHH = 14.9 Hz, −PyCH2N−, 2H), 4.01 (d, 2JHH = 12.8 Hz, −PyCH2N,
2H), 3.48 (s, −NCH2C(CH3)−, 2H), 2.55 (s, −NCH2C(CH3)3−,
2H), 1.12 (s, −C(CH3)3, 9H), 0.99 (s, −C(CH3)3, 9H). 13C NMR
(151 MHz, −30 °C, CD2Cl2): δ 158.4 (quat, CPy), 155.5 (quat. CPy),
136.7 (p-CPy), 124.6 (m-CPy), 121.7 (m-CPy), 75.7 (−NCH2C−), 71.2
(−NCH2C−), 67.7 (−PyCH2N), 63.7 (−PyCH2N), 36.4
(−CH2C(CH3)3), 34.2 (−CH2C(CH3)3), 30.3 (−C(CH3)3), 27.7
(−C(CH3)3). Anal. Found (calcd for C22H32N4CuI): C, 50.49 (50.48);
H, 6.22 (6.35); N, 9.56 (9.81).
2
−PyCH2N−, 2H), 4.02 (d, JHH = 13.6 Hz, −PyCH2N−, 2H), 3.62
(d, 2JHH = 15.3 Hz, −PyCH2N−, 2H), 3.02 (s, −NCH3, 3H), 2.51 (s,
−NCH3, 3H). 13C NMR (151 MHz, −30 °C, CD2Cl2): δ 155.6 (quat,
CPy), 154.8 (quat, CPy), 136.4 (p-CPy), 124.1 (m-CPy), 121.3 (m-CPy),
66.2 (−PyCH2N−), 64.9 (−PyCH2N−), 50.7 (−NCH3), 43.9
(−NCH3). Anal. Found (calcd for C16H20N4CuI): C, 41.77 (41.89);
H, 4.40 (4.39); N, 11.88 (12.21).
(TsN4)CuII (10). Bright-yellow crystalline solid. Isolated yield: 41 mg
(30%, low yield due to low solubility in dichloromethane). In CD2Cl2,
complex 10 remains fluxional even at −80 °C. The effective symmetry
of the ligand is C2v, which could be due to either the presence of only
E
Inorg. Chem. XXXX, XXX, XXX−XXX